Plasmablastic Lymphoma

• CLINICAL_TRIALS trial_result · 2026-03-13
  Clinical Trial Update: Belantamab Mafodotin In Plasmablastic Lymphoma & ALK+ Large B-Cell Lymphoma [Phase 2]

  A Phase 2 trial of belantamab mafodotin in relapsed/refractory plasmablastic lymphoma and ALK-positive large B-cell lymphoma was terminated,…

• CLINICAL_TRIALS trial_result · 2025-08-13
  Clinical Trial Update: RN1201injection for Relapsed/Refractory CD19+/BCMA+ Hematologic Malignancies [Phase 1]

  A Phase 1 clinical trial update for RN1201 injection in relapsed/refractory CD19+/BCMA+ hematologic malignancies, currently not recruiting.

• CLINICAL_TRIALS trial_result · 2025-06-29
  Clinical Trial Update: A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma [EARLY_Phase 1]

  This early-phase study tests daratumumab with dose-adjusted EPOCH for plasmablastic lymphoma and diffuse large B-cell lymphoma across stages…

• CLINICAL_TRIALS trial_result · 2024-10-16
  Clinical Trial Update: Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas [Phase 2]

  Phase 2 trial evaluating nivolumab with or without varlilumab in relapsed or refractory aggressive B-cell lymphomas, including multiple DLBC…

• CLINICAL_TRIALS trial_result · 2023-07-20
  Clinical Trial Update: Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant [Phase 1, Phase 2]

  This update reports results from a Phase 1/2 clinical trial of a gene therapy for HIV-related lymphomas in patients undergoing stem cell tra…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2021-12-08
  Clinical Trial Update: Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma [Phase 1, Phase 2]

  Phase 1/2 trial evaluating a combination of chemotherapy, rituximab, and ixazomib citrate in adults with various aggressive B-cell lymphomas…

• CLINICAL_TRIALS trial_result · 2021-10-19
  Clinical Trial Update: Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma [Phase 2]

  Phase II trial update for dose-adjusted EPOCH-Rrituximab in adults with untreated Burkitt lymphoma and c-MYC positive diffuse large B-cell l…